Abstract
Adjuvant chemotherapy of lung cancer including cisplatin is recommended for patients with lung cancer p-stage II-IIIA in case of complete resection. However, at the present, treatment outcomes are not necessarily satisfactory, and there is not effective chemotherapy resume for each patient individually. Establishing effective chemotherapy resume for each patient individually and practicing personalized medicine of lung cancer are expected for improving treatment outcomes after operation of p-stage II-IIIA patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
